T39.09 Poisoning by, adverse effect of and underdosing of other salicylates

Name of the Condition

• Poisoning by, adverse effect of and underdosing of other salicylates (ICD-10 Code: T39.09)

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to salicylates other than aspirin. These include medications like choline magnesium trisalicylate, salsalate, or diflunisal, which are used for pain relief, anti-inflammatory effects, or other therapeutic purposes. Toxicity or insufficient dosing can occur depending on dosage, individual factors, or interactions with other substances.

Causes

Poisoning or adverse effects may result from excessive intake, accidental or intentional overdose, or prolonged use of these salicylates. Underdosing occurs when insufficient amounts are administered, failing to achieve therapeutic goals. Interactions with other medications or underlying health conditions can also contribute to these outcomes.

Risk Factors

• Risk factors include advanced age, renal or hepatic impairment, chronic salicylate use, concurrent use of other medications (e.g., anticoagulants), and conditions like asthma or peptic ulcer disease. Children are particularly vulnerable to toxicity due to lower body weight.

Symptoms

• Symptoms vary by presentation: poisoning may cause nausea, vomiting, tinnitus, hyperventilation, or metabolic acidosis; adverse effects can include gastrointestinal irritation, bleeding, or allergic reactions; underdosing may result in persistent pain, inflammation, or lack of therapeutic benefit.

Diagnosis

Diagnosis involves clinical evaluation, including history of exposure or medication use, and laboratory tests to assess salicylate levels, electrolytes, or organ function. Imaging or additional tests may be used to rule out complications or underlying conditions.

Treatment Options

Treatment depends on the presentation: poisoning may require decontamination, supportive care, or antidotes; adverse effects may involve discontinuing the medication or managing symptoms; underdosing may necessitate dose adjustment or alternative therapies. Specific interventions are guided by severity and individual patient factors.

Prognosis and Follow-Up

Prognosis varies based on the type and severity of exposure. Poisoning outcomes depend on timely intervention, while adverse effects or underdosing may resolve with dose modification or discontinuation. Follow-up includes monitoring for recurrence, organ function, or therapeutic response.

Complications

Complications can include gastrointestinal bleeding, renal failure, respiratory distress, or metabolic disturbances in poisoning cases. Adverse effects may lead to chronic organ damage, and underdosing can result in persistent symptoms or treatment failure.

Lifestyle & Prevention

Preventive measures include proper medication storage, clear dosing instructions, and avoiding concurrent use of multiple salicylate products. Patients should be educated on signs of toxicity or insufficient dosing and when to seek care.

When to Seek Professional Help

Seek immediate medical attention for symptoms of poisoning (e.g., severe nausea, confusion, or difficulty breathing) or if adverse effects (e.g., uncontrolled bleeding) occur. Consult a healthcare provider for persistent symptoms or concerns about underdosing.

Tips for Medical Coders

Document the specific salicylate involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., dosage, intent, or interactions). Ensure clinical details support the coded scenario and align with the ICD-10-CM guidelines for T39.09.